• Skip to primary navigation
  • Skip to main content
  • Skip to footer

HepVu

HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

  • View the Map
  • Local Data
  • Find Services
  • News & Updates
  • Events
  • Tools & Resources
Home News & Updates Blogs & Q&As

Blogs & Q&As

Categories:

Awareness Days Blogs & Q&As HepVu Updates What's New in Viral Hepatitis Hep A Hep B Hep C Opioids COVID-19

May 18, 2022

HepVu’s One Question Series on Viral Hepatitis Elimination: Testing

May 12, 2022

Dr. Rita Isabel Lechuga on National Hispanic Hepatitis Awareness Day

Read More

April 5, 2022

Leading Viral Hepatitis Groups Launch the Hep ElimiNATION Project

Read More

March 21, 2022

Combatting Hepatitis C Among People Who Use Drugs in Appalachia

Read More

March 21, 2022

Dr. John W. Ward on the Coalition for Global Hepatitis Elimination (CGHE)

Read More

March 4, 2022

Hepatitis C Treatment Restrictions

Read More

November 18, 2021

Dr. Philip Spradling on the Hepatitis B Care Cascade

Read More

November 3, 2021

Liver Cancer and Viral Hepatitis

Read More

November 3, 2021

Dr. Samuel So on Liver Cancer & Hepatitis B and C

Read More

August 23, 2021

Dr. Eric Hall on County-Level Opioid Prescribing and Overdose Mortality Rates

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4

Sign up for HepVu updates.

Footer

AIDSVu HepVu

HepVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc.

  • About
  • FAQ
  • Data Methods
  • Datasets

Questions?
Info@HepVu.org

Media Inquiries
(202) 854-0480
Media@HepVu.org

Follow Us

  • Facebook
  • Twitter

© 2022 HepVu. All Rights Reserved.

  • Privacy Policy
  • Contact Us

Get HepVu in Your Inbox

Sign up to stay informed on new data, maps, expert Q&As, and infographics about Hepatitis C and opioids where you live.